Neutralizing antibody and CD8

CD8 T cells COVID-19 SARS-CoV-2 neutralization vaccination

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 10 12 2023
accepted: 08 02 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: epublish

Résumé

As severe acute respiratory coronavirus 2 (SARS-CoV-2) variants continue to emerge, it is important to characterize immune responses against variants which can inform on protection efficacies following booster vaccination. In this study, neutralizing breadth and antigen-specific CD8

Identifiants

DOI: 10.3389/fimmu.2024.1353353 PMID: 38571939 PMC: PMC10987722
pubmed: 38571939
doi: 10.3389/fimmu.2024.1353353
pmc: PMC10987722
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1353353

Informations de copyright

Copyright © 2024 Underwood, Sølund, Jacobsen, Binderup, Fernandez-Antunez, Mikkelsen, Inekci, Villadsen, Castruita, Pinholt, Fahnøe, Ramirez, Brix, Weis and Bukh.

Déclaration de conflit d'intérêts

Authors KJ, DI, and LB are employed by the company Immudex ApS. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Alexander P Underwood (AP)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Christina Sølund (C)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Kivin Jacobsen (K)

Immudex ApS, Copenhagen, Denmark.

Alekxander Binderup (A)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Carlota Fernandez-Antunez (C)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Lotte S Mikkelsen (LS)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Dilek Inekci (D)

Immudex ApS, Copenhagen, Denmark.

Signe Lysemose Villadsen (SL)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Jose A S Castruita (JAS)

Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark.

Mette Pinholt (M)

Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark.

Ulrik Fahnøe (U)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Santseharay Ramirez (S)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Liselotte Brix (L)

Immudex ApS, Copenhagen, Denmark.

Nina Weis (N)

Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Jens Bukh (J)

Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.

Classifications MeSH